These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differences in the acute pulmonary vascular effects of oxygen with nitric oxide and diltiazem: implications for the long-term treatment of pulmonary arterial hypertension. Day RW Congenit Heart Dis; 2013; 8(1):71-7. PubMed ID: 22891699 [TBL] [Abstract][Full Text] [Related]
3. Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing. Atz AM; Adatia I; Lock JE; Wessel DL J Am Coll Cardiol; 1999 Mar; 33(3):813-9. PubMed ID: 10080486 [TBL] [Abstract][Full Text] [Related]
4. Acute Vasodilator Response in Pediatric Pulmonary Arterial Hypertension: Current Clinical Practice From the TOPP Registry. Douwes JM; Humpl T; Bonnet D; Beghetti M; Ivy DD; Berger RM; J Am Coll Cardiol; 2016 Mar; 67(11):1312-23. PubMed ID: 26988953 [TBL] [Abstract][Full Text] [Related]
5. Inhaled nitric oxide in children with pulmonary hypertension and congenital mitral stenosis. Atz AM; Adatia I; Jonas RA; Wessel DL Am J Cardiol; 1996 Feb; 77(4):316-9. PubMed ID: 8607419 [TBL] [Abstract][Full Text] [Related]
6. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension. Ziegler JW; Ivy DD; Wiggins JW; Kinsella JP; Clarke WR; Abman SH Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1388-95. PubMed ID: 9817684 [TBL] [Abstract][Full Text] [Related]
7. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside. Kieler-Jensen N; Lundin S; Ricksten SE J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728 [TBL] [Abstract][Full Text] [Related]
8. Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension. Sitbon O; Humbert M; Jagot JL; Taravella O; Fartoukh M; Parent F; Herve P; Simonneau G Eur Respir J; 1998 Aug; 12(2):265-70. PubMed ID: 9727772 [TBL] [Abstract][Full Text] [Related]
9. Treatment of acute pulmonary hypertension with inhaled nitric oxide. Tönz M; von Segesser LK; Schilling J; Lüscher TF; Noll G; Leskosek B; Turina MI Ann Thorac Surg; 1994 Oct; 58(4):1031-5. PubMed ID: 7944746 [TBL] [Abstract][Full Text] [Related]
10. Inhaled nitric oxide in congenital heart disease. Roberts JD; Lang P; Bigatello LM; Vlahakes GJ; Zapol WM Circulation; 1993 Feb; 87(2):447-53. PubMed ID: 8425292 [TBL] [Abstract][Full Text] [Related]
11. Acute effect of oral prostacyclin and inhaled nitric oxide on pulmonary hypertension in children. Ichida F; Uese K; Hashimoto I; Hamamichi Y; Tsubata S; Fukahara K; Murakami A; Miyawaki T J Cardiol; 1997 Apr; 29(4):217-24. PubMed ID: 9127838 [TBL] [Abstract][Full Text] [Related]
12. Nitric oxide, oxygen, and prostacyclin in children with pulmonary hypertension. Turanlahti MI; Laitinen PO; Sarna SJ; Pesonen E Heart; 1998 Feb; 79(2):169-74. PubMed ID: 9538311 [TBL] [Abstract][Full Text] [Related]
15. Inhaled nitric oxide: effects on hemodynamics, myocardial contractility, and regional blood flow in dogs with mechanically induced pulmonary artery hypertension. Girard C; Fargnoli JM; Godin-Ribuot D; Dutheil V; Maitrasse B; Girardet P; Arvieux CC J Heart Lung Transplant; 1996 Jul; 15(7):700-8. PubMed ID: 8820786 [TBL] [Abstract][Full Text] [Related]
16. Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension. Hajian B; De Backer J; Vos W; Van Holsbeke C; Ferreira F; Quinn DA; Hufkens A; Claes R; De Backer W Int J Chron Obstruct Pulmon Dis; 2016; 11():1533-41. PubMed ID: 27462149 [TBL] [Abstract][Full Text] [Related]
17. Nitric oxide in the evaluation of congenital heart disease with pulmonary hypertension: factors related to nitric oxide response. Cannon BC; Feltes TF; Fraley JK; Grifka RG; Riddle EM; Kovalchin JP Pediatr Cardiol; 2005; 26(5):565-9. PubMed ID: 16132310 [TBL] [Abstract][Full Text] [Related]
18. Clinical Study of Acute Vasoreactivity Testing in Patients with Chronic Thromboembolic Pulmonary Hypertension. Xu QX; Yang YH; Geng J; Zhai ZG; Gong JN; Li JF; Tang X; Wang C Chin Med J (Engl); 2017 Feb; 130(4):382-391. PubMed ID: 28218209 [TBL] [Abstract][Full Text] [Related]